Category: 95-11-4

Recently I am researching about TRANSFUSION PREDICTION; PRIMARY SURGERY; IMPACT; RADIOTHERAPY; HEMOGLOBIN, Saw an article supported by the . Published in CHURCHILL LIVINGSTONE in EDINBURGH ,Authors: Rogers, SN; Horisk, K; Groom, P; Lowe, D. The CAS is 95-11-4. Through research, I have a further understanding and discovery of 5-Norbornene-2-carbonitrile. HPLC of Formula: C8H9N

Our main aims were to assess haemoglobin (Hb) concentrations from preoperative assessment to discharge from hospital, and to review which patients had blood transfusions and compliance with national transfusion guidelines. We studied a consecutive series of 131 patients between October 2016 and September 2017 who had either neck dissection or resection and free microvascular tissue transfer. Half the patients had soft tissue free flaps (n=65), 26% had composite free flaps (n = 34), and 24% neck dissection only (n =32). Using the WHO definition of anaemia, 4% (1/28) of patients who had neck dissections and 19% (16/85) of those who had free flaps were anaemic preoperatively. The median (IQR) Hb at discharge was 131 (119-144) g/L for patients who had neck dissections, 103 (95-114) g/L for those who had soft free flaps, and 95 (90-104) g/L for those who had composite free flaps. No patients who had neck dissection were given a red blood cell (RBC) transfusion, whereas they were given to 26/99 (26%) of those who had free flaps. Hb concentrations were checked after each unit in 31/39 transfusions (79%). Concentrations for those who had free flaps fell by about 30 g/L from admission to operation, and only four patients were given tranexamic acid peroperatively. Postoperatively Hb remained at similar concentrations until discharge, with 23/98 (24%) given iron orally on discharge. In terms of compliance with blood transfusion guidelines there was a notable absence of the use of tranexamic acid and of iron intravenously. An increase in their use could potentially reduce the number of blood transfusions required and the postoperative incidence of anaemia, and have a favourable effect on outcomes such as complications, fatigue, and overall quality of life. (C) 2019 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

HPLC of Formula: C8H9N. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Rogers, SN; Horisk, K; Groom, P; Lowe, D or concate me.

Reference:
Patent; Mitsui Chemicals, Inc.; KUMA, Shigetoshi; SAKATA, Michiharu; TOKUNAGA, Kouichi; SHIMAKAWA, Chitoshi; KAKINUMA, Naoyuki; FURUYA, Masayuki; TANAKA, Mamoru; EP2708527; (2014); A1;,
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

Recently I am researching about BOVINE CORNEAL OPACITY; TIME EXPOSURE TEST; HPLC/UPLC-SPECTROPHOTOMETRY; HAZARD IDENTIFICATION; APPLICABILITY DOMAIN; CHEMICALS; ASSAY; VALIDATION, Saw an article supported by the . HPLC of Formula: C8H9N. Published in PERGAMON-ELSEVIER SCIENCE LTD in OXFORD ,Authors: Alepee, N; Adriaens, E; Abo, T; Bagley, D; Desprez, B; Hibatallah, J; Mewes, K; Pfannenbecker, U; Sala, A; Van Rompay, AR; Verstraelen, S; McNamee, P. The CAS is 95-11-4. Through research, I have a further understanding and discovery of 5-Norbornene-2-carbonitrile

The focus of Cosmetics Europe’s programme on serious eye damage/eye irritation is on development of testing strategies and defined approaches for identification of ocular effects of chemicals in the context of OECD’s Guidance Document on an Integrated Approach on Testing and Assessment (IATA) for Serious Eye Damage and Eye Irritation. Cosmetics Europe created a comprehensive database of chemicals for which in vitro data are available with corresponding historical in vivo Draize eye data. This database allowed further exploration of the initially proposed strategies from the CON4EI project and to identify opportunities for refinement. The current analysis focused on the development of a defined approach, applicable to liquid non-surfactant chemicals, neat and in dilution, that can distinguish between the three UN GHS categories (Cat. 1, Cat. 2, and No Cat.). Combining the modified-protocol Short Time Exposure (STE) test method (OECD TG 491 with extension to highly volatile substances) with the Bovine Corneal Opacity and Permeability Laser Light-Based Opacitometer (BCOP LLBO) test method in a Bottom-Up approach identified 81.2% Cat. 1, 56.3% Cat. 2, and 85.3% No. Cat correctly, with an NPV of 96.7% and a PPV of 68.6%. Therefore, the performance of the defined approach was better than the standalone test methods.

HPLC of Formula: C8H9N. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Alepee, N; Adriaens, E; Abo, T; Bagley, D; Desprez, B; Hibatallah, J; Mewes, K; Pfannenbecker, U; Sala, A; Van Rompay, AR; Verstraelen, S; McNamee, P or concate me.

Reference:
Patent; Mitsui Chemicals, Inc.; KUMA, Shigetoshi; SAKATA, Michiharu; TOKUNAGA, Kouichi; SHIMAKAWA, Chitoshi; KAKINUMA, Naoyuki; FURUYA, Masayuki; TANAKA, Mamoru; EP2708527; (2014); A1;,
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

Quality Control of 5-Norbornene-2-carbonitrile. Recently I am researching about BOVINE CORNEAL OPACITY; TIME EXPOSURE TEST; HPLC/UPLC-SPECTROPHOTOMETRY; HAZARD IDENTIFICATION; APPLICABILITY DOMAIN; CHEMICALS; ASSAY; VALIDATION, Saw an article supported by the . Published in PERGAMON-ELSEVIER SCIENCE LTD in OXFORD ,Authors: Alepee, N; Adriaens, E; Abo, T; Bagley, D; Desprez, B; Hibatallah, J; Mewes, K; Pfannenbecker, U; Sala, A; Van Rompay, AR; Verstraelen, S; McNamee, P. The CAS is 95-11-4. Through research, I have a further understanding and discovery of 5-Norbornene-2-carbonitrile

The focus of Cosmetics Europe’s programme on serious eye damage/eye irritation is on development of testing strategies and defined approaches for identification of ocular effects of chemicals in the context of OECD’s Guidance Document on an Integrated Approach on Testing and Assessment (IATA) for Serious Eye Damage and Eye Irritation. Cosmetics Europe created a comprehensive database of chemicals for which in vitro data are available with corresponding historical in vivo Draize eye data. This database allowed further exploration of the initially proposed strategies from the CON4EI project and to identify opportunities for refinement. The current analysis focused on the development of a defined approach, applicable to liquid non-surfactant chemicals, neat and in dilution, that can distinguish between the three UN GHS categories (Cat. 1, Cat. 2, and No Cat.). Combining the modified-protocol Short Time Exposure (STE) test method (OECD TG 491 with extension to highly volatile substances) with the Bovine Corneal Opacity and Permeability Laser Light-Based Opacitometer (BCOP LLBO) test method in a Bottom-Up approach identified 81.2% Cat. 1, 56.3% Cat. 2, and 85.3% No. Cat correctly, with an NPV of 96.7% and a PPV of 68.6%. Therefore, the performance of the defined approach was better than the standalone test methods.

Quality Control of 5-Norbornene-2-carbonitrile. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Alepee, N; Adriaens, E; Abo, T; Bagley, D; Desprez, B; Hibatallah, J; Mewes, K; Pfannenbecker, U; Sala, A; Van Rompay, AR; Verstraelen, S; McNamee, P or concate me.

Reference:
Patent; Mitsui Chemicals, Inc.; KUMA, Shigetoshi; SAKATA, Michiharu; TOKUNAGA, Kouichi; SHIMAKAWA, Chitoshi; KAKINUMA, Naoyuki; FURUYA, Masayuki; TANAKA, Mamoru; EP2708527; (2014); A1;,
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

Recently I am researching about VERTICAL DISTRACTION; COMPLICATIONS; AUGMENTATION; IMPLANTS; DEVICES, Saw an article supported by the . Published in MEDICINA ORAL S L in VALENCIA ,Authors: Somoza-Martin, JM; Vazquez-Casal, A; Suarez-Cunqueiro, M; Garcia-Garcia, A; Gandara-Vila, P; Perez-Sayans, M. The CAS is 95-11-4. Through research, I have a further understanding and discovery of 5-Norbornene-2-carbonitrile. Name: 5-Norbornene-2-carbonitrile

Background: To perform a morphologic classification based on the results of bone augmentation after a distraction osteogenesis. Material and Methods: Thirty-four (34) patients (24 women and 10 men; mean age, 47.1 years (SD=9.5); age range, 23 to 62 years) underwent a total of 42 alveolar ridge distractions before the placement of a total of 89 dental implants. Ridge bone morphology was evaluated as the main ordinal variable. Chi-squared, Kruskal-Wallis and ANOVA one-way test were used. Results: Category I (30.95%): consisted of wide alveolar rim and no bone defects Category II (28.57%): wide alveolar rim, lateral bone surface concavity. Category III (23.81%): narrow alveolar rim, lateral bone surface concavity. Category IV (2.38%): distraction transport segment forming a bridge, without bone formed beneath and requiring guided bone regeneration. Category V (9.52%): return of the transport segment to its initial position due to the reverse rotation of the distractor screw. Category VI (4.76%): distraction transport segment completely lost. Subcategory D (28.57%), consisted of lingual deviation of the distraction axis, occurring in any of the categories I to IV. More men (76.9%) presented with category I (p<0.001). The use of the chisel resulted mainly in categories I and II (69.4%) (p<0.001). GBR was only required in 23.1% of the cases in Category I (p=0.011). The bone height achieved decreases as the category increases, due to the accompanying osteogenic limitations (p<0.001). The implants placed in category I were longer 11.5 +/- 0.9 mm (CI95% 10.9-11.9 mm) compared to those placed in category III with a length of 10.4 +/- 1.5 mm (CI95% 9.5-11.4 mm) (p=0.035). Conclusions: The alveolar ridge after distraction osteogenesis could be divided into six morphologic categories which provide a useful basis for decision-making regarding implant placement. Name: 5-Norbornene-2-carbonitrile. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Somoza-Martin, JM; Vazquez-Casal, A; Suarez-Cunqueiro, M; Garcia-Garcia, A; Gandara-Vila, P; Perez-Sayans, M or concate me.

Reference:
Patent; Mitsui Chemicals, Inc.; KUMA, Shigetoshi; SAKATA, Michiharu; TOKUNAGA, Kouichi; SHIMAKAWA, Chitoshi; KAKINUMA, Naoyuki; FURUYA, Masayuki; TANAKA, Mamoru; EP2708527; (2014); A1;,
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

Computed Properties of C8H9N. Recently I am researching about CAMELLIA-SINENSIS L.; BLACK TEAS; ICP-MS; BIOAVAILABILITY; INFUSIONS; CALCIUM; METALS; FE; CLASSIFICATION; CONTAMINATION, Saw an article supported by the Xunta de Galicia (Grupo de Referencia Competitiva)Xunta de Galicia [ED431C2018/19]; Conselleria de Educacion Program for the Development of Strategic Grouping in Materials -AEMAT at the University of Santiago de Compostela [ED431E2018/08]; Xunta de GaliciaXunta de GaliciaEuropean Commission; FEDER (EU)European Commission. Published in ELSEVIER in AMSTERDAM ,Authors: Alnaimat, AS; Barciela-Alonso, MC; Herbello-Hermelo, P; Dominguez-Gonzalez, R; Bermejo-Barrera, P. The CAS is 95-11-4. Through research, I have a further understanding and discovery of 5-Norbornene-2-carbonitrile

Bioaccessibility of trace elements (Li, Be, Ti, Ga, Cu, Ag, Hg, Cd, Cs, Pt, Tl, Pb, As, Cr, Co, Ni, V, Se, Sn and Sb) and major elements (Rb, Ba, Al, Fe, Zn, Si, Ca, Mg, Mn, Mo, Sr, P and K) in tea infusions has been assessed using an in vitro dialyzability protocol. Gastric simulation (using pepsin solution) and intestinal simulation (using pancreatin and bile salts) were used to perform the in vitro digestion. ICP-MS, ICP-OES and FAES were used for elements determination in digested tea leaves, their infusions and the dialyzate fractions from tea infusions. Microwaves assisted acid digestion was used for the total element determination in tea leaves, while tea infusions were prepared by brewing tea leaves for 5 min in boiling water. The LODs for elements determined in tea leaves were in the range of 0.11-656 ng g(-1) and 0.02-145.6 mu g g(-1) for trace and major elements, respectively. For elements’ determination in tea infusions, the LODs were ranged between 0.23 and 399.9 ng L-1 for trace elements and 0.2-1248 mu g L-1 for major elements. The LODs for the elements in the dialyzable fraction varied from 0.018 to 142 mu g L-1. The accuracy of the total element determination was evaluated using certified reference materials (Tea Leaves INCT-TL-1 and Rye Grass). The analytical recoveries were also assessed for analyzed elements in digested tea leaves (95-114%) and their infusions (92-115%), showing good recoveries. Among the studied elements, K was the most abundant element in tea leaves and tea infusions in almost all samples, followed by Ca, Mg, and P. Zn, Cs, and K showed the highest dialyzability percentages up to 84%, 76%, and 54%, respectively, followed by Si and Ca and K that show moderate to high dialyzability percentages. The accuracy of the dialysis process was evaluated using a mass-balance study.

Computed Properties of C8H9N. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Alnaimat, AS; Barciela-Alonso, MC; Herbello-Hermelo, P; Dominguez-Gonzalez, R; Bermejo-Barrera, P or concate me.

Reference:
Patent; Mitsui Chemicals, Inc.; KUMA, Shigetoshi; SAKATA, Michiharu; TOKUNAGA, Kouichi; SHIMAKAWA, Chitoshi; KAKINUMA, Naoyuki; FURUYA, Masayuki; TANAKA, Mamoru; EP2708527; (2014); A1;,
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

In 2019 BRIT J ORAL MAX SURG published article about TRANSFUSION PREDICTION; PRIMARY SURGERY; IMPACT; RADIOTHERAPY; HEMOGLOBIN in [Rogers, S. N.] Edge Hill Univ, Fac Hlth & Social Care, Evidence Based Practice Res Ctr EPRC, St Helens Rd, Ormskirk L39 4QP, England; [Rogers, S. N.; Horisk, K.] Aintree Univ Hosp NHS Fdn Trust, Reg Maxillofacial Unit, Liverpool L9 1AE, Merseyside, England; [Groom, P.] Aintree Univ Hosp NHS Fdn Trust, Liverpool L9 1AE, Merseyside, England; [Lowe, D.] Edge Hill Univ, Fac Hlth, Evidence Based Practice Res Ctr EPRC, St Helens Rd, Ormskirk L39 4QP, England in 2019, Cited 24. The Name is 5-Norbornene-2-carbonitrile. Through research, I have a further understanding and discovery of 95-11-4. Category: nitriles-buliding-blocks

Our main aims were to assess haemoglobin (Hb) concentrations from preoperative assessment to discharge from hospital, and to review which patients had blood transfusions and compliance with national transfusion guidelines. We studied a consecutive series of 131 patients between October 2016 and September 2017 who had either neck dissection or resection and free microvascular tissue transfer. Half the patients had soft tissue free flaps (n=65), 26% had composite free flaps (n = 34), and 24% neck dissection only (n =32). Using the WHO definition of anaemia, 4% (1/28) of patients who had neck dissections and 19% (16/85) of those who had free flaps were anaemic preoperatively. The median (IQR) Hb at discharge was 131 (119-144) g/L for patients who had neck dissections, 103 (95-114) g/L for those who had soft free flaps, and 95 (90-104) g/L for those who had composite free flaps. No patients who had neck dissection were given a red blood cell (RBC) transfusion, whereas they were given to 26/99 (26%) of those who had free flaps. Hb concentrations were checked after each unit in 31/39 transfusions (79%). Concentrations for those who had free flaps fell by about 30 g/L from admission to operation, and only four patients were given tranexamic acid peroperatively. Postoperatively Hb remained at similar concentrations until discharge, with 23/98 (24%) given iron orally on discharge. In terms of compliance with blood transfusion guidelines there was a notable absence of the use of tranexamic acid and of iron intravenously. An increase in their use could potentially reduce the number of blood transfusions required and the postoperative incidence of anaemia, and have a favourable effect on outcomes such as complications, fatigue, and overall quality of life. (C) 2019 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Category: nitriles-buliding-blocks. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Rogers, SN; Horisk, K; Groom, P; Lowe, D or concate me.

Reference:
Patent; Mitsui Chemicals, Inc.; KUMA, Shigetoshi; SAKATA, Michiharu; TOKUNAGA, Kouichi; SHIMAKAWA, Chitoshi; KAKINUMA, Naoyuki; FURUYA, Masayuki; TANAKA, Mamoru; EP2708527; (2014); A1;,
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

Authors Makrilakis, K; Kalpourtzi, N; Ioannidis, I; Iraklianou, S; Raptis, A; Sotiropoulos, A; Gavana, M; Vantarakis, A; Kantzanou, M; Hadjichristodoulou, C; Chlouverakis, G; Trypsianis, G; Voulgari, PV; Alamanos, Y; Touloumi, G; Liatis, S in ELSEVIER IRELAND LTD published article about CARDIOVASCULAR MORBIDITY; ADULTS; POPULATION; MELLITUS; BURDEN; HEALTH; TRENDS; SAMPLE; EPIDEMIOLOGY; SURVEILLANCE in [Makrilakis, Konstantinos; Ioannidis, Ioannis; Iraklianou, Stella; Raptis, Athanasios; Sotiropoulos, Alexis; Liatis, Stavros] Hellen Diabet Assoc, Athens, Greece; [Makrilakis, Konstantinos; Liatis, Stavros] Natl & Kapodistrian Univ Athens, Med Sch, Dept Propaedeut Internal Med 1, Athens, Greece; [Kalpourtzi, Natasa; Kantzanou, Maria; Touloumi, Giota] Natl & Kapodistrian Univ Athens, Med Sch, Dept Hyg Epidemiol & Med Stat, Athens, Greece; [Ioannidis, Ioannis] Konstantopoulio Hosp, Dept Internal Med 1, Nea Ionia, Greece; [Ioannidis, Ioannis] Konstantopoulio Hosp, Diabet Ctr, Nea Ionia, Greece; [Iraklianou, Stella] Gen Hosp Tzaneio, Dept Internal Med 3, Piraeus, Greece; [Raptis, Athanasios] Natl & Kapodistrian Univ Athens, Med Sch, Attikon Univ Hosp, Dept Propaedeut Internal Med 2,Res Unit, Athens, Greece; [Raptis, Athanasios] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Diabet Ctr, Athens, Greece; [Sotiropoulos, Alexis] Gen Hosp Nikaia Piraeus, Internal Med Dept 3, Nikea, Greece; [Sotiropoulos, Alexis] Gen Hosp Nikaia Piraeus, Diabet Ctr, Nikea, Greece; [Gavana, Magda] Aristotle Univ Thessaloniki, Med Sch, Dept Primary Hlth Care Gen Practice & Hlth Serv R, Thessaloniki, Greece; [Vantarakis, Apostolos] Univ Patras, Med Sch, Publ Hlth, Patras, Greece; [Hadjichristodoulou, Christos] Univ Thessaly, Med Fac, Dept Hyg & Epidemiol, Larisa, Greece; [Chlouverakis, Grigoris] Univ Crete, Sch Med, Lab Biostat, Iraklion, Greece; [Trypsianis, Grigoris] Democritus Univ Thrace, Med Sch, Lab Med Stat, Thrace, Greece; [Voulgari, Paraskevi V.] Univ Ioannina, Med Sch, Dept Internal Med, Ioannina, Greece; [Alamanos, Yannis] Inst Epidemiol Prevent Med & Publ Hlth, Corfu, Greece in 2021, Cited 43. Recommanded Product: 95-11-4. The Name is 5-Norbornene-2-carbonitrile. Through research, I have a further understanding and discovery of 95-11-4

Aims: To report the results of the first national Health Examination Survey (HES) on the prevalence of diabetes, its pharmacologic treatment and level of control, as well as pre -diabetes in Greece. Methods: Data were derived from the National Survey of Morbidity and Risk Factors (EMENO), in a randomly selected, representative sample of the adult Greek population. Sampling weights were applied to adjust for study design and post-stratification weights to match sample age/sex distribution to the population. Non-response was adjusted by inverse probability weighting. Weighted prevalence estimates are provided. Results: A total of 4393 persons with HbA1c and/or fasting plasma glucose measurements were included. Total diabetes prevalence was 11.9% (95% CI: 10.9-12.9), known diabetes 10.4% (9.5-11.4), and unknown 1.5% (1.1-1.9), with considerable increase in older age groups and no difference between genders. Pre-diabetes prevalence was 12.4% (11.4-13.6). The majority of persons with known diabetes were receiving metformin. Of those with known diabetes (and measured HbA1c), 70.9% were well controlled (HbA1c <7.0%). Conclusions: This first representative national HES showed high prevalence of diabetes in Greece, with low prevalence of unknown diabetes. Pre-diabetes prevalence is also substantial. These results will hopefully enable national authorities develop tailored and efficient strategies for disease prevention and management. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Makrilakis, K; Kalpourtzi, N; Ioannidis, I; Iraklianou, S; Raptis, A; Sotiropoulos, A; Gavana, M; Vantarakis, A; Kantzanou, M; Hadjichristodoulou, C; Chlouverakis, G; Trypsianis, G; Voulgari, PV; Alamanos, Y; Touloumi, G; Liatis, S or concate me.. Recommanded Product: 95-11-4

Reference:
Patent; Mitsui Chemicals, Inc.; KUMA, Shigetoshi; SAKATA, Michiharu; TOKUNAGA, Kouichi; SHIMAKAWA, Chitoshi; KAKINUMA, Naoyuki; FURUYA, Masayuki; TANAKA, Mamoru; EP2708527; (2014); A1;,
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

An article Prevalence of diabetes and pre -diabetes in Greece. Results of the First National Survey of Morbidity and Risk Factors (EMENO) study WOS:000632552500005 published article about CARDIOVASCULAR MORBIDITY; ADULTS; POPULATION; MELLITUS; BURDEN; HEALTH; TRENDS; SAMPLE; EPIDEMIOLOGY; SURVEILLANCE in [Makrilakis, Konstantinos; Ioannidis, Ioannis; Iraklianou, Stella; Raptis, Athanasios; Sotiropoulos, Alexis; Liatis, Stavros] Hellen Diabet Assoc, Athens, Greece; [Makrilakis, Konstantinos; Liatis, Stavros] Natl & Kapodistrian Univ Athens, Med Sch, Dept Propaedeut Internal Med 1, Athens, Greece; [Kalpourtzi, Natasa; Kantzanou, Maria; Touloumi, Giota] Natl & Kapodistrian Univ Athens, Med Sch, Dept Hyg Epidemiol & Med Stat, Athens, Greece; [Ioannidis, Ioannis] Konstantopoulio Hosp, Dept Internal Med 1, Nea Ionia, Greece; [Ioannidis, Ioannis] Konstantopoulio Hosp, Diabet Ctr, Nea Ionia, Greece; [Iraklianou, Stella] Gen Hosp Tzaneio, Dept Internal Med 3, Piraeus, Greece; [Raptis, Athanasios] Natl & Kapodistrian Univ Athens, Med Sch, Attikon Univ Hosp, Dept Propaedeut Internal Med 2,Res Unit, Athens, Greece; [Raptis, Athanasios] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Diabet Ctr, Athens, Greece; [Sotiropoulos, Alexis] Gen Hosp Nikaia Piraeus, Internal Med Dept 3, Nikea, Greece; [Sotiropoulos, Alexis] Gen Hosp Nikaia Piraeus, Diabet Ctr, Nikea, Greece; [Gavana, Magda] Aristotle Univ Thessaloniki, Med Sch, Dept Primary Hlth Care Gen Practice & Hlth Serv R, Thessaloniki, Greece; [Vantarakis, Apostolos] Univ Patras, Med Sch, Publ Hlth, Patras, Greece; [Hadjichristodoulou, Christos] Univ Thessaly, Med Fac, Dept Hyg & Epidemiol, Larisa, Greece; [Chlouverakis, Grigoris] Univ Crete, Sch Med, Lab Biostat, Iraklion, Greece; [Trypsianis, Grigoris] Democritus Univ Thrace, Med Sch, Lab Med Stat, Thrace, Greece; [Voulgari, Paraskevi V.] Univ Ioannina, Med Sch, Dept Internal Med, Ioannina, Greece; [Alamanos, Yannis] Inst Epidemiol Prevent Med & Publ Hlth, Corfu, Greece in 2021, Cited 43. Quality Control of 5-Norbornene-2-carbonitrile. The Name is 5-Norbornene-2-carbonitrile. Through research, I have a further understanding and discovery of 95-11-4

Aims: To report the results of the first national Health Examination Survey (HES) on the prevalence of diabetes, its pharmacologic treatment and level of control, as well as pre -diabetes in Greece. Methods: Data were derived from the National Survey of Morbidity and Risk Factors (EMENO), in a randomly selected, representative sample of the adult Greek population. Sampling weights were applied to adjust for study design and post-stratification weights to match sample age/sex distribution to the population. Non-response was adjusted by inverse probability weighting. Weighted prevalence estimates are provided. Results: A total of 4393 persons with HbA1c and/or fasting plasma glucose measurements were included. Total diabetes prevalence was 11.9% (95% CI: 10.9-12.9), known diabetes 10.4% (9.5-11.4), and unknown 1.5% (1.1-1.9), with considerable increase in older age groups and no difference between genders. Pre-diabetes prevalence was 12.4% (11.4-13.6). The majority of persons with known diabetes were receiving metformin. Of those with known diabetes (and measured HbA1c), 70.9% were well controlled (HbA1c <7.0%). Conclusions: This first representative national HES showed high prevalence of diabetes in Greece, with low prevalence of unknown diabetes. Pre-diabetes prevalence is also substantial. These results will hopefully enable national authorities develop tailored and efficient strategies for disease prevention and management. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Makrilakis, K; Kalpourtzi, N; Ioannidis, I; Iraklianou, S; Raptis, A; Sotiropoulos, A; Gavana, M; Vantarakis, A; Kantzanou, M; Hadjichristodoulou, C; Chlouverakis, G; Trypsianis, G; Voulgari, PV; Alamanos, Y; Touloumi, G; Liatis, S or concate me.. Quality Control of 5-Norbornene-2-carbonitrile

Reference:
Patent; Mitsui Chemicals, Inc.; KUMA, Shigetoshi; SAKATA, Michiharu; TOKUNAGA, Kouichi; SHIMAKAWA, Chitoshi; KAKINUMA, Naoyuki; FURUYA, Masayuki; TANAKA, Mamoru; EP2708527; (2014); A1;,
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

In 2019 GREEN CHEM published article about LIQUID-PHASE HYDROGENATION; HIGHLY-ACTIVE HYDROGENATION; ORGANIC FRAMEWORK NODES; ASYMMETRIC HYDROGENATION; SELECTIVE HYDROGENATION; CATALYTIC-HYDROGENATION; COMPLEXES; ISOOCTENES; KINETICS; CO in [Pews-Davtyan, Anahit; Scharnagl, Florian Korbinian; Hertrich, Maximilian Franz; Kreyenschulte, Carsten; Bartling, Stephan; Lund, Henrik; Jackstell, Ralf; Beller, Matthias] Univ Rostock, Leibniz Inst Katalyse eV, Albert Einstein Str 29a, D-18059 Rostock, Germany in 2019, Cited 62. The Name is 5-Norbornene-2-carbonitrile. Through research, I have a further understanding and discovery of 95-11-4. Recommanded Product: 95-11-4

Catalytic hydrogenation of olefins using noble metal catalysts or pyrophoric RANEY (R) nickel is of high importance in the chemical industry. From the point of view of green and sustainable chemistry, design and development of Earth-abundant, less toxic, and more environmentally friendly catalysts are highly desirable. Herein, we report the convenient preparation of active cobalt catalysts and their application in hydrogenations of a wide range of terminal and internal carbon-carbon double bonds in water under mild conditions. Catalysts are prepared on multi-gram scale by pyrolysis of cobalt acetate and uracil, guanine, adenine or l-tryptophan. The most active material Co-Ura/C-600 showed good productivity in industrially relevant hydrogenation of diisobutene to isooctane and in natural oil hardening.

Recommanded Product: 95-11-4. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Pews-Davtyan, A; Scharnagl, FK; Hertrich, MF; Kreyenschulte, C; Bartling, S; Lund, H; Jackstell, R; Beller, M or concate me.

Reference:
Patent; Mitsui Chemicals, Inc.; KUMA, Shigetoshi; SAKATA, Michiharu; TOKUNAGA, Kouichi; SHIMAKAWA, Chitoshi; KAKINUMA, Naoyuki; FURUYA, Masayuki; TANAKA, Mamoru; EP2708527; (2014); A1;,
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

Product Details of 95-11-4. Makrilakis, K; Kalpourtzi, N; Ioannidis, I; Iraklianou, S; Raptis, A; Sotiropoulos, A; Gavana, M; Vantarakis, A; Kantzanou, M; Hadjichristodoulou, C; Chlouverakis, G; Trypsianis, G; Voulgari, PV; Alamanos, Y; Touloumi, G; Liatis, S in [Makrilakis, Konstantinos; Ioannidis, Ioannis; Iraklianou, Stella; Raptis, Athanasios; Sotiropoulos, Alexis; Liatis, Stavros] Hellen Diabet Assoc, Athens, Greece; [Makrilakis, Konstantinos; Liatis, Stavros] Natl & Kapodistrian Univ Athens, Med Sch, Dept Propaedeut Internal Med 1, Athens, Greece; [Kalpourtzi, Natasa; Kantzanou, Maria; Touloumi, Giota] Natl & Kapodistrian Univ Athens, Med Sch, Dept Hyg Epidemiol & Med Stat, Athens, Greece; [Ioannidis, Ioannis] Konstantopoulio Hosp, Dept Internal Med 1, Nea Ionia, Greece; [Ioannidis, Ioannis] Konstantopoulio Hosp, Diabet Ctr, Nea Ionia, Greece; [Iraklianou, Stella] Gen Hosp Tzaneio, Dept Internal Med 3, Piraeus, Greece; [Raptis, Athanasios] Natl & Kapodistrian Univ Athens, Med Sch, Attikon Univ Hosp, Dept Propaedeut Internal Med 2,Res Unit, Athens, Greece; [Raptis, Athanasios] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Diabet Ctr, Athens, Greece; [Sotiropoulos, Alexis] Gen Hosp Nikaia Piraeus, Internal Med Dept 3, Nikea, Greece; [Sotiropoulos, Alexis] Gen Hosp Nikaia Piraeus, Diabet Ctr, Nikea, Greece; [Gavana, Magda] Aristotle Univ Thessaloniki, Med Sch, Dept Primary Hlth Care Gen Practice & Hlth Serv R, Thessaloniki, Greece; [Vantarakis, Apostolos] Univ Patras, Med Sch, Publ Hlth, Patras, Greece; [Hadjichristodoulou, Christos] Univ Thessaly, Med Fac, Dept Hyg & Epidemiol, Larisa, Greece; [Chlouverakis, Grigoris] Univ Crete, Sch Med, Lab Biostat, Iraklion, Greece; [Trypsianis, Grigoris] Democritus Univ Thrace, Med Sch, Lab Med Stat, Thrace, Greece; [Voulgari, Paraskevi V.] Univ Ioannina, Med Sch, Dept Internal Med, Ioannina, Greece; [Alamanos, Yannis] Inst Epidemiol Prevent Med & Publ Hlth, Corfu, Greece published Prevalence of diabetes and pre -diabetes in Greece. Results of the First National Survey of Morbidity and Risk Factors (EMENO) study in 2021, Cited 43. The Name is 5-Norbornene-2-carbonitrile. Through research, I have a further understanding and discovery of 95-11-4.

Aims: To report the results of the first national Health Examination Survey (HES) on the prevalence of diabetes, its pharmacologic treatment and level of control, as well as pre -diabetes in Greece. Methods: Data were derived from the National Survey of Morbidity and Risk Factors (EMENO), in a randomly selected, representative sample of the adult Greek population. Sampling weights were applied to adjust for study design and post-stratification weights to match sample age/sex distribution to the population. Non-response was adjusted by inverse probability weighting. Weighted prevalence estimates are provided. Results: A total of 4393 persons with HbA1c and/or fasting plasma glucose measurements were included. Total diabetes prevalence was 11.9% (95% CI: 10.9-12.9), known diabetes 10.4% (9.5-11.4), and unknown 1.5% (1.1-1.9), with considerable increase in older age groups and no difference between genders. Pre-diabetes prevalence was 12.4% (11.4-13.6). The majority of persons with known diabetes were receiving metformin. Of those with known diabetes (and measured HbA1c), 70.9% were well controlled (HbA1c <7.0%). Conclusions: This first representative national HES showed high prevalence of diabetes in Greece, with low prevalence of unknown diabetes. Pre-diabetes prevalence is also substantial. These results will hopefully enable national authorities develop tailored and efficient strategies for disease prevention and management. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Makrilakis, K; Kalpourtzi, N; Ioannidis, I; Iraklianou, S; Raptis, A; Sotiropoulos, A; Gavana, M; Vantarakis, A; Kantzanou, M; Hadjichristodoulou, C; Chlouverakis, G; Trypsianis, G; Voulgari, PV; Alamanos, Y; Touloumi, G; Liatis, S or concate me.. Product Details of 95-11-4

Reference:
Patent; Mitsui Chemicals, Inc.; KUMA, Shigetoshi; SAKATA, Michiharu; TOKUNAGA, Kouichi; SHIMAKAWA, Chitoshi; KAKINUMA, Naoyuki; FURUYA, Masayuki; TANAKA, Mamoru; EP2708527; (2014); A1;,
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts